FrancophonIA/ELRC3.0 huggingface dataset:
English: Hiacyntowa 39 60-175 Poznań Poland
Maltese: Hiacyntowa 39 60-175
English: C/ Jorge Comín (Médico Pediatra)
Maltese: PENSA PHARMA, S.A.U. C/ Jorge Comín (Médico Pediatra)
English: S.C. TERAPIA S.A. Str. Fabricii nr. 124 Cluj Napoca România
Maltese: Fabricii nr. 124 Cluj Napoca România
English: Teva Pharma - Produtos Farmacêuticos, Lda Lagoas Park, Edifício 1 - 3º 2740-264 Porto Salvo Portugal
Maltese: Teva Pharma - Produtos Farmacêuticos, Lda Lagoas Park, Edifício 1 - 3º 2740-264
English: Polígono Industrial Areta 31620 Huarte (PAMPLONA) Spain
Maltese: Polígono Industrial Areta 31620
English: DILATAN 20 mg, comprimate filmate, 20 mg 20mg
Maltese: DILATAN 20 mg, comprimate filmate, 20 mg
English: PORTORA 35 MG TABLETY S PRODLOUŽENÝM UVOLŇOVÁNÍM
Maltese: PORTORA 35 MG TABLETY S PRODLOUŽENÝM
English: Jaba Recordati, S. A. Lagoas Park, Edificio 5, Torre C, Piso 3 2740298 Porto Salvo Portugal
Maltese: Lagoas Park, Edificio 5, Torre C, Piso 3 2740298 Porto Salvo Portugal
English: Ethifarm Sp. z o. o. ul.
Maltese: Sp. z o. o.
English: Servier Pharma d.o.o.
Maltese: Servier Pharma d.o.o. Pot k sejmiscu 33
English: DILATAN MR 35 mg, comprimate filmate cu eliberare modificată, 35 mg
Maltese: MR 35 mg, comprimate filmate cu eliberare modificată, 35 mg
English: AJC INVEST
Maltese: INVEST
English: Actavis Group PTC ehf., Hafnarfjördur Reykjavikurvegur 76-78 220 Hafnarfjördur Iceland
Maltese: Actavis Group PTC ehf., Hafnarfjördur Reykjavikurvegur 76-78 220
English: S.C. VIM SPECTRUM S.R.L., Şos.
Maltese: S.R.L., Şos.
English: Poland ratiopharm GmbH Graf-Arco-Strasse 3 Ulm, 89079
Maltese: Il-Polanja ratiopharm GmbH Graf-Arco-Strasse 3 Ulm, 89079
English: Trimetazidina Mepha 20 mg Comprimidos Revestidos 20 mg
Maltese: Trimetazidina Mepha 20 mg Comprimidos Revestidos
English: ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. ul.
Maltese: Przedsiębiorstwo Farmaceutyczne S.A.
English: Slovak Republic ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Maltese: Repubblika Slovakka ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: Bulgaria ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Maltese: Bulgarija ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: TRIMETAZIDIN SANDOZ 35 MG
Maltese: TRIMETAZIDIN SANDOZ 35
English: Trimetazidina Jaba 20 mg Comprimidos revestidos
Maltese: Jaba 20 mg Comprimidos revestidos
English: RATIOPHARM GMBH Graf Arco Strasse 3 89079 Ulm Germany
Maltese: GMBH Graf Arco Strasse 3 89079 Ulm Germany
English: LABORMED PHARMA S.A. Bd. Theodor Pallady nr. 44B sector 3, Bucureşti România
Maltese: 44B sector 3, Bucureşti România
English: Trimetazidina Labesfal 20 mg Comprimidos Revestidos 20 mg
Maltese: Trimetazidina Labesfal 20 mg Comprimidos Revestidos
English: Actavis Group PTC ehf Reykjavkurvegi 76-78 220 Hafnarfiroi Iceland
Maltese: Actavis Group PTC ehf Reykjavkurvegi 76-78 220
English: Drops
Maltese: Qawwa
English: Actavis Group PTC ehf., Reykjavikurvegi 76-78, 220 Hafnarfjorður Iceland
Maltese: Actavis Group PTC ehf., Reykjavikurvegi 76-78, 220
English: Hungary ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Maltese: Ungerija ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
English: Germany ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
Maltese: Ġermanja ratiopharm GmbH Graf-Arco-Str. 3 89079 Ulm Germany
English: PENSA PHARMA, S.A.U.
Maltese: Jaba Recordati, S. A.
English: Actavis Group PTC ehf., Reykjavikurvegi 76-78 220 Hafnarfjordur Iceland
Maltese: Actavis Group PTC ehf., Reykjavikurvegi 76-78 220
English: Film-coated tablets
Maltese: Pillola miksija
English: TRIMETAZIDIN MYLAN 35 MG
Maltese: TRIMETAZIDIN MYLAN 35
English: 1 February 2016 EMA/492394/2015 Corr. 1
Maltese: EMA/828143/2015
English: Common side effects (seen between 1 and 10 patients in 100) have been reported with linseed.
Maltese: Effetti sekondarji komuni (osservati f'bejn pazjent 1 u 10 minn kull 100) ġew irrapportati biż-żerriegħa tal-kittien.
English: This effect may reduce gastrointestinal discomfort.
Maltese: Dan l-effett jista' jnaqqas l-iskumdità gastrointestinali.
English: Linseed swells with water in the gut to form a thick jelly-like substance (mucilage).
Maltese: Iż-żerriegħa tal-kittien tintefaħ bl-ilma fl-imsaren biex tifforma sustanza qisha jelly (muċilaġni).
English: Linseed
Maltese: Żerriegħa tal-Kittien
English: It should also not be used in patients with abnormal constriction or blockage of the digestive tract, paralysis in the gut, or abnormal widening of the large intestine, or with diseases of the oesophagus (the tube between mouth and stomach).
Maltese: Ma għandhiex tintuża wkoll f'pazjenti b'kostrizzjoni anomala jew sadd fis-sistema diġestiva, paraliżi fl-imsaren, jew twessigħ anomalu tal-musrana l-kbira, jew b'mard tal-esofagu (it-tubu bejn il-ħalq u l-istonku).
English: Further information on the HMPC assessment of linseed medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: It is likely that linseed mucilage coats the lining of the digestive tract and thus protects it from irritation.
Maltese: Huwa improbabbli li l-muċilaġni taż-żerriegħa tal-kittien jiksi r-rita tal-passaġġ diġestiv u b'hekk jipproteġih minn irritazzjoni.
English: Very rarely, allergic reactions, sometimes severe, have been reported.
Maltese: B'mod rari ħafna, ġew irrapportati reazzjonijiet allerġiċi, xi drabi severi.
English: Linseed is the common name for the seeds of the plant Linum usitatissimum L. The dried, ripe seeds for medicinal use are obtained from plants that have been cultivated.
Maltese: Fil-valutazzjoni tiegħu, l-HMPC ikkunsidra numru ta' studji kliniċi li juru l-effett taż-żerriegħa tal-kittien fuq l-istitikezza u l-ippurgar iebes.
English: Further information on the risks associated with linseed medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Maltese: Aktar informazzjoni dwar ir-riskji assoċjati mal-mediċini li fihom iż-żerriegħa tal-kittien, inklużi lprekawzjonijiet xierqa għall-użu sigur tagħhom, tinsab fil-monografu taħt it-tab ‘Id-dokumenti kollha' fis-sit web tal-Aġenzija:
English: Although an early clinical study on linseed for the treatment of gastrointestinal discomfort is available, it was too limited to be used them as evidence and the HMPC's conclusions for this indication are based on the medicines' long-standing use.
Maltese: Għalkemm huwa disponibbli studju kliniku bikri dwar iż-żerriegħa tal-kittien għall-kura ta' skumdità gastrointestinali, dan kien limitat wisq biex jintuża bħala evidenza u l-konklużjonijiet tal-HMPC għal din l-indikazzjoni huma bbażati fuq l-użu fit-tul tal-mediċini.
English: Advice should be taken from a doctor or a qualified healthcare professional if constipation persists after 3 days of using linseed or if mild gastrointestinal discomfort persists after 7 days of using linseed.
Maltese: Għandu jittieħed parir mingħand tabib jew professjonista fil-kura tas-saħħa kkwalifikat jekk l-istitikezza tippersisti wara 3 ijiem ta' użu taż-żerriegħa tal-kittien jew jekk skumdità gastrointestinali ħafifa tippersisti wara 7 ijiem ta' użu taż-żerriegħa tal-kittien.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of linseed.
Maltese: Dan id-dokument huwa sommarju tal-konklużjonijiet xjentifiċi li wasal għalihom il-Kumitat għallProdotti Mediċinali Erbali (HMPC) dwar l-użu mediċinali taż-żerriegħa tal-kittien.
English: Linseed should only be used in adults and adolescent aged over 12 years.
Maltese: Iż-żerriegħa tal-kittien għandha tintuża biss f'adulti u adolexxenti li għandhom iktar minn 12-il sena.
English: What are the risks associated with linseed medicines?
Maltese: X'inhuma r-riskji assoċjati mal-mediċini li fihom iż-żerriegħa tal-kittien?
English: Zona Industrial da Abrunheira Edifício 10 - Sintra Business Park 2710-089 Sintra Portugal
Maltese: Zona Industrial da Abrunheira Edifício 10 - Sintra Business Park 2710-089 Sintra
English: Baxter MédicoFarmacêutica, Lda.
Maltese: Baxter Médico-Farmacêutica, Lda.
English: Czech Republic BAXTER CZECH spol.
Maltese: Ir-Repubblika Ċeka BAXTER CZECH spol.
English: Baxter Deutschland GmbH
Maltese: Baxter Deutschland GmbH Edisonstr.
English: Pouet de Camilo, 2 46394 Ribarroja del Turia (Valencia) Spain
Maltese: Ribarroja del Turia (Valencia) Spain
English: ul.
Maltese: Bd.
English: Belgium BAXTER S.A. Bd. René Branquart 80 7860 Lessines
Maltese: René Branquart 80 7860 Lessines Belgium
English: Poligono Industrial Sector 14
Maltese: Poligono Industrial Sector 14 Pouet de Camilo, 2
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states for Numeta G13%E and Numeta G16%E emulsions for infusion
Maltese: Lista tal-ismijiet, għamla farmaċewtika (għamliet farmaċewtiċi), qawwa (qawwiet) tal-prodott(i) mediċinali, mnejn jingħata, id-detentur(i) ta` l-awtorizzazzjoni għat-tqegħid fis-suq fl-istati membri
English: MUMETA G16%E, emulsión para perfusión
Maltese: NUMETA G16%E, emulsión para perfusión
English: MUMETA G13%E, emulsión para perfusión
Maltese: NUMETA G13%E, emulsión para perfusión
English: Numeta G 16 % E Emulsion zur Infusio
Maltese: NUMETA G16%E emulsie voor infusie
English: Edisonstr.
Maltese: L-Iżvezja
English: Baxter Healthcare GmbH
Maltese: Baxter Healthcare GmbH Stella-Klein-Löw-Weg 15 1020
English: The application was submitted to Germany as reference Member State and Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, France, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and the United Kingdom as concerned Member States.
Maltese: L-applikazzjoni ġiet sottomessa lill-Ġermanja bħala l-Istat Membru ta' Referenza u lillAwstrija, il-Belġju, il-Bulgarija, Ċipru, ir-Repubblika Ċeka, id-Danimarka, l-Estonja, Franza, il-Greċja, lUngerija, l-Irlanda, l-Italja, il-Latvja, il-Litwanja, il-Lussemburgu, Malta, l-Olanda, il-Polonja, ilPortugall, ir-Rumanija, is-Slovakkja, is-Slovenja, Spanja u lir-Renju Unit bħala l-Istati Membri involuti.
English: The decentralised procedure (DE/V/0122/002/DC) started on 12 November 2010.
Maltese: Il-proċedura deċentralizzata (DE/V/0122/002/DC) bdiet fit-12 ta' Novembru 2010.
English: International non-proprietary name (INN): florfenicol
Maltese: Isem internazzjonali komuni (INN): florfenikolu
English: Oral explanations were given on 15 May 2012.
Maltese: Spjegazzjonijiet orali ngħataw fil-15 ta' Mejju 2012.
English: Florfenicol is structurally related to thiamphenicol and has a similar pharmacological profile.
Maltese: Is-sustanza florfenikolu hija strutturalment relatata mat-tijamfenikolu u għandha profil farmakoloġiku simili.
English: This was a ‘hybrid application' according to Article 13(3) Directive 2001/82/EC, as amended, referring to the reference product, Nuflor Swine 300 mg/ml solution for injection (FR/V/0118/001).
Maltese: Din kienet ‘applikazzjoni ibrida' skont lArtikolu 13(3) tad-Direttiva 2001/82/KE kif emendata, li tirreferi għall-prodott ta' referenza, Nuflor Swine 300 mg/ml soluzzjoni għal injezzjoni (FR/V/0118/001).
English: Nuflor Swine Once 450 mg per ml solution for injection contains florfenicol as active ingredient and is intended for use in pigs for the treatment of respiratory infections caused by strains of Actinobacillus pleuropneumoniae, Haemophilus parasuis and Pasteurella multocida susceptible to florfenicol.
Maltese: Nuflor Swine Once 450 mg/ml soluzzjoni għal injezzjoni fih il-florfenikolu bħala s-sustanza attiva u tfassal għall-użu fuq il-majjali għall-kura ta' infezzjonijiet respiratorji kkawżati minn razez ta' Actinobacillus pleuropneumoniae, Haemophilus parasuis u Pasteurella multocida suxxettibbli għallflorfenikolu.
English: The applicant, Intervet International BV, submitted an application for a decentralised procedure for Nuflor Swine Once 450 mg/ml solution for injection.
Maltese: L-applikant, Intervet International BV, issottometta applikazzjoni għal proċedura deċentralizzata għal Nuflor Swine Once 450 mg/ml soluzzjoni għal injezzjoni.
English: The Committee appointed Prof. Christian Friis as rapporteur and Dr Cornelia Ibrahim as co-rapporteur.
Maltese: Il-Kumitat ħatar lil Prof. Christian Friis bħala rapporteur u lil Dr Cornelia Ibrahim bħala korapporteur.
English: Potential serious risks were identified during the decentralised procedure by Denmark regarding the cumulative failure rate observed in the pivotal clinical field trial and potential for development of antimicrobial resistance to florfenicol.
Maltese: Matul il-proċedura deċentralizzata mid-Danimarka ġew identifikati riskji serji potenzjali dwar ir-rata kumulattiva ta' falliment osservata fil-prova klinika pivotali fuq il-post u l-potenzjali għall-iżvilupp ta' reżistenza antimikrobika għall-florfenikolu.
English: Opinion following an Article 33(4)0F referral for Nuflor Swine Once 450 mg/ml solution for injection
Maltese: Opinjoni wara referenza għall-Artikolu 33(4)0F rigward Nuflor Swine Once 450 mg/ml soluzzjoni għal injezzjoni
English: Nuflor Swine Once 450 mg/ml solution for injection differs from the reference veterinary medicinal product by a higher concentration of active substance, single administration, a change in therapeutic indication but also by a different co-solvent.
Maltese: Nuflor Swine Once 450 mg/ml soluzzjoni għal injezzjoni jvarja mill-prodott mediċinali veterinarju ta' referenza minħabba konċentrazzjoni ogħla ta' sustanza attiva, għoti uniku, bidla fl-indikazzjoni terapewtika imma wkoll minħabba kosolvent differenti.
English: Written explanations were provided by the applicant on 20 March 2012.
Maltese: Spjegazzjonijiet bil-miktub ingħataw millapplikant fl-20 ta' Marzu 2012.
English: The proposed dose is 30 mg florfenicol per kg bodyweight given by intramuscular administration as a single injection.
Maltese: Id-doża proposta hija 30 mg florfenikolu għal kull kg tal-piż tal-ġisem li tingħata ġolmuskoli bħala injezzjoni unika.
English: On 27 September 2012 a plenary meeting of the Standing Committee on Veterinary Medicinal Products took place and on 3 October 2012 the European Commission sent a letter to the CVMP requesting a reconsideration of the opinion adopted on 13 June 2012.
Maltese: Fis-27 ta' Settembru 2012 saret laqgħa plenarja tal-Kumitat Permanenti għall-Prodotti Mediċinali Veterinarji u fit-3 ta' Ottubru 2012 il-Kummissjoni Ewropea bagħtet ittra lis-CVMP li fiha talbet rikonsiderazzjoni tal-opinjoni adottata fit-13 ta' Ġunju 2012.
English: The Committee re-appointed Prof Christian Friis as rapporteur and Dr Cornelia Ibrahim as co-rapporteur for the reconsideration procedure.
Maltese: Il-Kumitat ħatar mill-ġdid lil Prof. Christian Friis bħala rapporteur u lil Dr Cornelia Ibrahim bħala ko-rapporteur għall-proċedura ta' rikunsiderazzjoni.
English: On 31 August 2012, the Netherlands submitted an objection to the opinion adopted by CVMP on 13 June 2012 during the written phase of the Standing Committee procedure.
Maltese: Fil-31 ta' Awwissu 2012 l-Olanda ppreżentat oġġezzjoni għall-opinjoni adottata mis-CVMP fit13 ta' Ġunju 2012, matul il-fażi bil-miktub tal-proċedura tal-Kumitat Permanenti.
English: The reconsideration procedure started on 10 October 2012.
Maltese: Il-proċedura ta' rikunsiderazzjoni bdiet fl-10 ta' Ottubru 2012.
English: Oral explanations were given by the applicant on 10 January 2013.
Maltese: Spjegazzjonijiet orali ngħataw mill-applikant fl-10 ta' Jannar 2013.
English: On 19 December 2011, the reference Member State, Germany, notified to the European Medicines Agency that the CMD(v) had failed to reach an agreement regarding the product and referred the matter to the CVMP pursuant to Article 33(4) of Directive 2001/82/EC.
Maltese: Fid-19 ta' Diċembru 2011, l-Istat Membru ta' referenza, il-Ġermanja, innotifikat lill-Aġenzija Ewropea għall-Mediċini li s-CMD(v) naqas milli jilħaq ftehim dwar il-prodott u konsegwentement il-kwistjoni ġiet riferuta lis-CVMP skont l-Artikolu 33(4) tad-Direttiva 2001/82/KE.
English: On 7 February 2013 the CVMP adopted a reconsidered opinion, concluding that the application does not comply with Article 13 of Directive 2001/82/EC, and consequently does not satisfy the criteria for authorisation in respect of efficacy.
Maltese: Fis-7 ta' Frar 2013 is-CVMP adotta opinjoni kkunsidrata mill-ġdid, u kkonkluda li l-applikazzjoni ma tikkonformax mal-Artikolu 13 tad-Direttiva 2001/82/KE u għaldaqstant ma tissodisfax il-kriterji għal awtorizzazzjoni fir-rigward tal-effikaċja.
English: Opinion following an Article 33(4)1 referral for Nuflor Swine Once 450 mg/ml solution for injection
Maltese: Nuflor Swine Once 450 mg/ml soluzzjoni għal injezzjoni
English: The reconsidered opinion was converted into a Decision by the European Commission on 16 May 2013.
Maltese: L-opinjoni rikonsiderata nqelbet f'Deċiżjoni mill-Kummissjoni Ewropea fis-16 ta' Mejju 2013.
English: 16 May 2013
Maltese: 16 ta' Mejju 2013 EMA/349454/2013
English: Ventricular extrasystoles.
Maltese: Extrasystoles ventrikulari.
English: 40 avenue George V 75008 Paris France
Maltese: 40 Avenue George V 75008 Paris Franza
English: Unpredictable***
Maltese: Mhux prevedibbli***
English: This medicine is an emergency treatment.
Maltese: Din il-mediċina hi trattament ta' emerġenza.
English: Allergy (hypersensitivity)
Maltese: Allerġija (sensittività eċċessiva)
English: Avenue Louise 480 1050 Brussels Belgium
Maltese: Avenue Louise 480 1050 Brussels Il-Belġju
English: Centre de Production de Semoy 2, rue du Pressoir Vert F-45400 Semoy France
Maltese: Centre de Production de Semoy 2, rue du Pressoir Vert F-54400
English: Gastrointestinal (digestive) problems
Maltese: Problemi gastrointestinali (diġestivi)
English: • problems with memory
Maltese: • problemi fil-memorja
English: Creatinine Total and conjugate bilirubin** Triglycerides Cholesterol Total protein Glucose Albumin Alkaline phosphatase
Maltese: Krejatinina Bilirubina totali u konjugata** Triglycerides Kolesterol Proteina totali Glukosju Albumina Alkaline phosphatase
English: - haemodialysis.
Maltese: - emodijaliżi.
English: Analysers used: ACL Futura (Instrumentation Laboratory), Axsym/Architect (Abbott), BM Coasys (Boehringer Mannheim), CellDyn 3700 (Abbott), Clinitek 500 (Bayer), Cobas Integra 700, 400 (Roche), Gen-S Coultronics, Hitachi 917, STA
Maltese: (Boehringer Mannheim), CellDyn 3700 (Abbott), Clinitek 500 (Bayer), Cobas Integra 700, 400 (Roche), Gen-S Coultronics, Hitachi 917, STA
English: Date of first authorisation: 23 November 2007 Date of latest renewal: 20 July 2012
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni: 23 ta' Novembru, 2007
English: • The active substance is hydroxocobalamin.
Maltese: • Is-sustanza attiva hi hydroxocobalamin.
English: Haematology Erythrocytes Haematocrit
Maltese: Ematoloġija Eritroċiti Ematokrit
English: / SEMOY 2, rue du Pressoir Vert 45400 Semoy
Maltese: Merck Santé s.a.s. / SEMOY 2, rue du Pressoir Vert 45400
English: Documentation on efficacy is available for 54 paediatric patients.
Maltese: Id-dokumentazzjoni fuq effikaċja hi disponibbli għal 54 pazjent pedjatriku.
English: 24 hours with the exception of bilirubin (up to 4 days)
Maltese: 24 siegħa bleċċezzjoni talbilirubina (sa 4 ijiem)
English: Survival at Hour 4, N (%) 7 (41) Survival at Day 14, N (%) 3 (18)
Maltese: Sopravivenza f'Siegħa 4, N (%) 7 (41) Sopravivenza f'Jum 14, N (%)
English: * ≥ 10% interference observed on at least one analyser ** Artificially decreased using the diazo method *** Inconsistent results
Maltese: * ≥ 10% interferenza osservata fuq mill-inqas analizzatur wieħed ** Imnaqqas artifiċjalment bl-użu tal-metodu diazo *** Riżultati inkonsistenti
English: Prothrombin time (PT) Quick or INR
Maltese: Ħin tal-protrombin (PT) Quick jew INR
English: • Acute renal failure with acute tubular necrosis, renal impairment, urine calcium oxalate crystals present (see section 4.4).
Maltese: • Insuffiċjenza akuta tal-kliewi b'nekrosi tubulari akuta, indeboliment tal-kliewi, preżenza ta' kristalli ta' calcium oxalate fl-awrina (ara sezzjoni 4.4).
English: Aspartate aminotransferase (AST)
Maltese: Phosphate Uric acid Aspartate aminotransferase (AST)
English: Mean corpuscular volume (MCV) Leucocytes
Maltese: Medja tal-volum korpuskolari (MCV) Lewkoċiti
English: Artificially increased*
Maltese: Imnaqqas Artifiċjalment*
English: Observed in vitro interferences of hydroxocobalamin with laboratory tests
Maltese: Interferenzi osservata in vitro ta' hydroxocobalamin ma' testijiet tal-laboratorju
English: A total of 347 subjects were exposed to hydroxocobalamin in clinical studies.
Maltese: Totali ta' 347 pazjent kienu esposti għal hydroxocobalamin fi studji kliniċi.
English: Chemical incompatibility was observed with the mixture of hydroxocobalamin reconstituted solution and the following medicinal products: epinephrine, lidocaine hydrochloride, adenosine, atropine, midazolam, ketamin, succinylcholine chloride, amiodarone hydrochloride, sodium bicarbonate, sodium thiosulfate, sodium nitrite, and has been reported with ascorbic acid.
Maltese: L-inkompatibilità kimika kienet osservata mat-taħlita fis-soluzzjoni rikostitwita ta' hydroxocobalamin u l-prodotti mediċinali li ġejjin: epinephrine, lidocaine hydrochloride, adenosine, atropine, midazolam, ketamin, succinylcholine chloride, amiodarone hydrochloride, sodium bicarbonate, sodium thiosulfate, sodium nitrite, u kienet irrappurtata ma' ascorbic acid.
English: The maximum total recommended dose is 10 g for adults, and 140 mg/kg in children up to a maximum of 10 g.
Maltese: Id-doża massima rakkomandata hi ta' 10 g għall-adulti, u 140 mg/kg fit-tfal sa massimu ta' 10 g.
English: • Cyanide-poisoned patients
Maltese: • Pazjenti avvelenati b'cyanide
English: No interference observed
Maltese: L-ebda interferenza osservata
English: Physical incompatibility (particle formation) was observed with the mixture of hydroxocobalamin reconstituted solution and the following medicinal products: diazepam, dobutamine, dopamine, fentanyl, nitroglycerin, pentobarbital, phenytoin sodium, propofol and thiopental.
Maltese: L-inkompatibilità fiżika (formazzjoni ta' partiċelli) kienet osservata mat-taħlita fis-soluzzjoni rikostitwita ta' hydroxocobalamin u l-prodotti mediċinali li ġejjin: diazepam, dobutamine, dopamine, fentanyl, nitroglycerin, pentobarbital, phenytoin sodium, propofol u thiopental.
English: Interference following a 10 g dose can be expected to last up to an additional 24 hours.
Maltese: L-interferenza wara doża ta' 10 g tista' tkun mistennija li ddum sa 24 siegħa addizzjonali.
English: Hydroxocobalamin may interfere with all urine colorimetric parameters.
Maltese: Hydroxocobalamin jista' jinterferixxi mal-parametri kolorimetriċi ta' l-awrina.
English: Combination with another cyanide antidote: Chemical incompatibility was observed with sodium thiosulfate and sodium nitrite.
Maltese: L-inkompatibilità kimika kienet osservata ma' sodium thiosulfate u sodium nitrite.
English: Adults: The maximum total recommended dose is 10 g.
Maltese: Id-doża massima totali rakkomandata hi 10 g.
English: For the purpose of ambulatory use, Cyanokit may be exposed during short periods to the temperature variations of usual transport (15 days submitted to temperatures ranging from 5°C to 40°C), transport in the desert (4 days submitted to temperatures ranging from 5°C to 60°C) and freezing/defrosting cycles (15 days submitted to temperatures ranging from -20°C to 40°C).
Maltese: Għal skopijiet ta' użu ambulatorju, Cyanokit jista' jkun espost waqt perjodi qosra għal varjazzjonijiet tat-temperatura waqt it-trasport normali (15-il jum espost għal temperaturi li jvarjaw minn 5°C sa 40°C), trasport fid-deżert (4 ijiem espost għal temperaturi li jvarjaw minn 5°C sa 60°C) u ċikli ta' ffriżar/iddefrostjar (15-il jum espost għal temperaturi li jvarjaw minn -20°C sa 40°C).